Leading science, pioneering therapies
CRM Publications

The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.

TitleThe STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.
Publication TypeJournal Article
Year of Publication2018
AuthorsCampana L, Lewis PJStarkey, Pellicoro A, Aucott RL, Man J, O'Duibhir E, Mok SE, Ferreira-González S, Livingstone E, Greenhalgh SN, Hull KL, Kendall TJ, Vernimmen D, Henderson NC, Boulter L, Gregory CD, Feng Y, Anderton SM, Forbes SJ, Iredale JP
JournalJ Immunol
Volume200
Issue3
Pagination1169-1187
Date Published2018 Feb 01
ISSN1550-6606
Abstract

The disposal of apoptotic bodies by professional phagocytes is crucial to effective inflammation resolution. Our ability to improve the disposal of apoptotic bodies by professional phagocytes is impaired by a limited understanding of the molecular mechanisms that regulate the engulfment and digestion of the efferocytic cargo. Macrophages are professional phagocytes necessary for liver inflammation, fibrosis, and resolution, switching their phenotype from proinflammatory to restorative. Using sterile liver injury models, we show that the STAT3-IL-10-IL-6 axis is a positive regulator of macrophage efferocytosis, survival, and phenotypic conversion, directly linking debris engulfment to tissue repair.

DOI10.4049/jimmunol.1701247
Alternate JournalJ. Immunol.
PubMed ID29263216
PubMed Central IDPMC5784823
Grant List / / Wellcome Trust / United Kingdom
Publication institute
CRM